Analysis of palliative care treatment among head and neck patients with cancer: National perspective

Head Neck. 2021 Mar;43(3):805-815. doi: 10.1002/hed.26532. Epub 2020 Nov 5.

Abstract

Background: To analyze the characteristics and survival patterns of patients with head and neck squamous cell carcinoma (SCC) who received palliative treatment during their first course of treatment.

Methods: Cohort analysis utilizing the National Cancer Data Base (NCDB) of patients with a diagnosis of oral cavity/oropharyngeal, hypopharyngeal, and laryngeal SCC. Statistical analysis included multivariate logistic regression and Cox Hazard ratio modeling, and Kaplan-Meier survival analysis.

Results: 165 081 patients were included, of which 2747 patients received palliative treatment. Patients who received palliative treatment tended to be ≥65 years old, black, Charlson/Deyo score ≥3, hypopharyngeal cancer, stage (III-IV), with Medicaid insurance (P < .05). Patients were more likely to be treated with palliative intent if they underwent chemotherapy/radiotherapy and declined surgery (P < .001) compared to patients who underwent surgery and declined chemotherapy/radiotherapy (P = .006).

Conclusions: Palliative care use in head and neck oncology is associated with older patients, non-whites, Medicaid patients, and nonsurgically treated patients.

Keywords: head and neck oncology; outcome studies; palliative care; squamous cell carcinoma; survival.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Carcinoma, Squamous Cell* / therapy
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Palliative Care
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck / therapy
  • United States